Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver pathology in obesity.

Arief Suriawinata1, M Isabel Fiel

  • 1Dartmouth Hitchcock Medical Center, Department of Pathology, One Medical Center Drive, Lebanon, NH 03756, USA. Arief.A.Suriawinata@hitchcock.org

Seminars in Liver Disease
|December 18, 2004
PubMed
Summary

Obesity-related liver disease, like nonalcoholic steatohepatitis, is common. Liver biopsy is key for diagnosis and staging, and weight loss can reverse liver damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.

JHEP reports : innovation in hepatology·2026
Same author

High Incidence of Undiagnosed Hepatocellular Carcinoma in Transplant Recipients With Metabolic-Associated Steatotic Liver Disease.

Clinical transplantation·2026
Same author

Liver Biopsy Features May Help Distinguish Drug-Induced Autoimmune-Like Hepatitis From Idiopathic Autoimmune Hepatitis.

Archives of pathology & laboratory medicine·2026
Same author

Predicting targeted therapy resistance in non-small cell lung cancer using multimodal machine learning.

Journal of thoracic disease·2025
Same author

Improving Colorectal Cancer Screening and Risk Assessment through Predictive Modeling on Medical Images and Records.

The American journal of pathology·2025
Same author

Confirmation of the donor origin of de novo hepatocellular carcinoma after liver transplant using microsatellite analysis.

American journal of clinical pathology·2025

Area of Science:

  • Hepatology
  • Gastroenterology
  • Metabolic Syndrome

Background:

  • Obesity-related liver disease, including nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, is a growing concern in developed nations.
  • Nonalcoholic steatohepatitis is a hepatic manifestation of metabolic syndrome, leading to fibrosis, cirrhosis, and hepatocellular carcinoma.
  • Liver biopsy is the gold standard for diagnosing, evaluating, staging, and grading nonalcoholic steatohepatitis.

Purpose of the Study:

  • To discuss obesity-related liver diseases, focusing on histopathology in liver biopsies.
  • To examine obesity-related hepatocellular carcinoma.
  • To review the impact of weight loss interventions on liver histopathology.

Main Methods:

  • Review of pathological features in liver biopsies from obese patients.
  • Analysis of liver biopsy findings for staging and grading nonalcoholic steatohepatitis.
  • Evaluation of concomitant liver diseases that may accelerate steatohepatitis progression.

Main Results:

  • Liver biopsy is crucial for assessing nonalcoholic steatohepatitis and other liver conditions in obese patients.
  • Weight loss interventions can reduce liver inflammation, promote fibrosis regression, and potentially reverse cirrhosis.
  • Histopathological examination guides treatment decisions and assesses treatment efficacy.

Conclusions:

  • Nonalcoholic steatohepatitis requires accurate diagnosis and staging via liver biopsy.
  • Weight loss is a critical therapeutic strategy for managing obesity-related liver disease, showing potential for significant histopathological improvement.
  • Liver biopsy is essential for comprehensive patient management and understanding treatment outcomes.

Related Experiment Videos